FOLFIRI

	WikiDoc Resources for FOLFIRI
Articles
Most recent articles on FOLFIRI Most cited articles on FOLFIRI Review articles on FOLFIRI Articles on FOLFIRI in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on FOLFIRI Images of FOLFIRI Photos of FOLFIRI Podcasts & MP3s on FOLFIRI Videos on FOLFIRI
Evidence Based Medicine
Cochrane Collaboration on FOLFIRI Bandolier on FOLFIRI TRIP on FOLFIRI
Clinical Trials
Ongoing Trials on FOLFIRI at Clinical Trials.gov Trial results on FOLFIRI Clinical Trials on FOLFIRI at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on FOLFIRI NICE Guidance on FOLFIRI NHS PRODIGY Guidance FDA on FOLFIRI CDC on FOLFIRI
Books
Books on FOLFIRI
News
FOLFIRI in the news Be alerted to news on FOLFIRI News trends on FOLFIRI
Commentary
Blogs on FOLFIRI
Definitions
Definitions of FOLFIRI
Patient Resources / Community
Patient resources on FOLFIRI Discussion groups on FOLFIRI Patient Handouts on FOLFIRI Directions to Hospitals Treating FOLFIRI Risk calculators and risk factors for FOLFIRI
Healthcare Provider Resources
Symptoms of FOLFIRI Causes & Risk Factors for FOLFIRI Diagnostic studies for FOLFIRI Treatment of FOLFIRI
Continuing Medical Education (CME)
CME Programs on FOLFIRI
International
FOLFIRI en Espanol FOLFIRI en Francais
Business
FOLFIRI in the Marketplace Patents on FOLFIRI
Experimental / Informatics
List of terms related to FOLFIRI

Overview

FOLFIRI is a chemotherapy regimen for treatment of colorectal cancer, made up of the drugs

The regimen consists of:

Irinotecan (180 mg/m² IV over 90 minutes) concurrently with folinic acid (400 mg/m² [or 2 x 250 mg/m²] IV over 120 minutes).

Followed by fluorouracil (400-500 mg/m² IV bolus) then fluorouracil (2400-3000mg/m² intravenous infusion over 46 hours).

This cycle is typically repeated every two weeks.

The dosages shown above may vary from cycle to cycle.